Wednesday 26 October 2011 – Janssen Pharmaceutica, Beerse, Belgium
Program

 

You can download this program from the pdf in attachment at the bottom of this page.

8:30-9:00
 
Coffee
 
 
9:00-9:05
 
Welcome
 
Mark Martens,
President of BelTox
 
Morning session 1: Introductory lectures
(chair : J. Baumeister -Ablynx & M. Cornet – UCB Pharma)

9:05-10:05
 
Safety assessment of biologics : specific requirements
for vaccines and antibodies
 
R. Foster,
CiToxLAB, F
 
10:05-11:05
 
Safety assessment of biologics : regulatory perspectives

 

J.W. van der Laan,
RIVM, Nl
 
11:05-11:25 Coffee break
 

Morning session 2: Non-clinical safety evaluation of vaccines
(chair : L. Segal – GSK Biologicals)


11:25-12:05
 
Prophylactic vaccine toxicology case study

 

S. Gould
Sanofi-Pasteur, F
 
12:05-12:45
 
Vaccine adjuvants safety evaluation

 

N. Garçon,
GSK Biologicals, B
 
12:45-13:45
 
Lunch and networking
 
 
Afternoon session: Non-clinical safety evaluation of antibodies and nanobodies
(chair : G. Bailey & I. Smyej – Johnson & Johnson)

13:45-14:25
 
Challenges in developmental and reproductive toxicity testing of biopharmaceuticals
 
G. Weinbauer,
Covance, D
 
14:25-14:55 Choice of species for reproductive toxicity studies with biopharmaceuticals A. Cauvin,
UCB Pharma, B
 
14:55-15:15
 
Coffee break
 
 
15:15-15:55
 
Immunogenicity testing in support of nonclinical
studies of biotherapeutics: experiences and challenges
 
M.P. Bouche,
Ablynx, B
 
15:55-16:35
 
Safety assessment of monoclonal antibodies : Specific requirements for infectious diseases

 

T.Kwaks,
Crucell, Nl
16:35-17:25
 
Safety assessment of Nanobodies : experienes and outlook

 

S. Jacobs,
Ablynx, B
 
17:25-17:35
 
Concluding remarks

 

M. Cornet, Beltox &
chair of the Organising Committee
17:35-19:00
 
Reception and networking

 

 
Organising Committee : Judith Baumeister (Ablynx), Annick Cauvin (UCB Pharma),
Miranda Cornet (UCB Pharma),
Ilham Smyej (Johnson & Johnson), Lawrence Segal (GSK Biologicals)
with the technical assistance of Marleen Hallam (BelTox) and Karin Van Tulden (Johnson & Johnson)